相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC
S. J. Antonia et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer
S. J. Antonia et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer
Peter Goldstraw et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
Phase III Study of Surgery Versus Definitive Concurrent Chemoradiotherapy Boost in Patients With Resectable Stage IIIA(N2) and Selected IIIB Non-Small-Cell Lung Cancer After Induction Chemotherapy and Concurrent Chemoradiotherapy (ESPATUE)
Wilfried Ernst Erich Eberhardt et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Induction chemoradiation in stage IIIA/N2 non-small-cell lung cancer: a phase 3 randomised trial
Miklos Pless et al.
LANCET (2015)
Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial
Nick Thatcher et al.
LANCET ONCOLOGY (2015)
Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study
Jeffrey D. Bradley et al.
LANCET ONCOLOGY (2015)
Lungscape: Resected Non-Small-Cell Lung Cancer Outcome by Clinical and Pathological Parameters
Solange Peters et al.
JOURNAL OF THORACIC ONCOLOGY (2014)
Randomized Phase II Study of Pemetrexed, Carboplatin, and Thoracic Radiation With or Without Cetuximab in Patients With Locally Advanced Unresectable Non-Small-Cell Lung Cancer: Cancer and Leukemia Group B Trial 30407
Ramaswamy Govindan et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Phase II Study of Cetuximab in Combination With Chemoradiation in Patients With Stage IIIA/B Non-Small-Cell Lung Cancer: RTOG 0324
George R. Blumenschein et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Concurrent cetuximab and radiotherapy after docetaxel-cisplatin induction chemotherapy in stage III NSCLC: Satellite-A phase II study from the Swedish Lung Cancer Study Group
A. Hallqvist et al.
LUNG CANCER (2011)
Pneumonectomy is a valuable treatment option after neoadjuvant therapy for stage III non-small-cell lung cancer
Walter Weder et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2010)
The European Respiratory Society and European Society of Thoracic Surgeons clinical guidelines for evaluating fitness for radical treatment (surgery and chemoradiotherapy) in patients with lung cancer
Alessandro Brunelli et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2009)
ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy)
A. Brunelli et al.
EUROPEAN RESPIRATORY JOURNAL (2009)
Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial
Robert Pirker et al.
LANCET (2009)
Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial
Kathy S. Albain et al.
LANCET (2009)
Neoadjuvant chemotherapy and radiotherapy followed by surgery in selected patients with stage IIIB non-small-cell lung cancer: a multicentre phase II trial
Roger Stupp et al.
LANCET ONCOLOGY (2009)
Preoperative Staging of Lung Cancer with Combined PET-CT.
Barbara Fischer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Improved results of induction chemoradiation before surgical intervention for selected patients with stage IIIA-N2 non-small cell lung cancer
Karl L. Uy et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2007)
ESTS guidelines for preoperative lymph node staging for non-small cell lung cancer
Paul De Leyn et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2007)
Physiologic evaluation of the patient with lung cancer being considered for resectional surgery - ACCP evidenced-based clinical practice guidelines (2nd edition)
Gene L. Colice et al.
CHEST (2007)
Pulmonary resection after high-dose and low-dose chest irradiation
RJ Cerfolio et al.
ANNALS OF THORACIC SURGERY (2005)
Kinetics of EGFR expression during fractionated irradiation varies between different human squamous cell carcinoma lines in nude mice
W Eicheler et al.
RADIOTHERAPY AND ONCOLOGY (2005)
Induction chemoradiotherapy and surgical resection for selected stage IIIB non-small-cell lung cancer
Y Ichinose et al.
ANNALS OF THORACIC SURGERY (2003)
Mediastinal lymph node clearance after docetaxel-cisplatin Neoadjuvant chemotherapy is prognostic of survival in patients with stage IIIA pN2 non-small-cell lung cancer:: A multicenter phase II trial
DC Betticher et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Benefit of surgery after chemoradiotherapy in stage IIIB (T4 and/or N3) non-small cell lung cancer
DH Grunenwald et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2001)
Epidermal growth factor receptor as a genetic therapy target for carcinoma cell radiosensitization
G Lammering et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)